CARDLYTICS INC (CDLX)

US14161W1053 - Common Stock

3.655  -1.56 (-29.85%)

Buy % Consensus

49

ChartMill assigns a Buy % Consensus number of 49% to CDLX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 4.39. This target is 20% above the current price.
CDLX was analyzed by 11 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about CDLX.
In the previous month the buy percentage consensus was at a similar level.
CDLX was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 3.663.544.084.395.25 - -3.28% 11.63% 20.00% 43.64%
Up and Down Grades
Date Firm Action Rating
2024-11-07 Needham Reiterate Hold
2024-10-11 Evercore ISI Group Initiate In-Line
2024-08-16 Northland Capital Markets Downgrade Outperform -> Market Perform
2024-08-15 B of A Securities Downgrade Neutral -> Underperform
2024-08-08 Lake Street Downgrade Buy -> Hold
2024-08-08 Needham Downgrade Buy -> Hold
2024-08-08 Northland Capital Markets Maintains Outperform -> Outperform
2024-06-20 B of A Securities Reiterate Neutral
2024-06-18 Northland Capital Markets Initiate Outperform
2024-06-11 Needham Reiterate Buy -> Buy
2024-05-09 Needham Maintains Buy -> Buy
2024-05-09 Craig-Hallum Maintains Buy -> Buy
2024-04-09 Needham Maintains Buy -> Buy
2024-03-15 Lake Street Maintains Buy -> Buy
2024-03-15 Needham Maintains Buy -> Buy
2024-03-15 Craig-Hallum Upgrade Hold -> Buy
2024-01-30 Needham Reiterate Buy -> Buy
2023-11-29 Lake Street Initiate Buy
2023-11-09 Needham Maintains Buy -> Buy
2023-08-02 Needham Maintains Buy -> Buy
2023-08-02 JP Morgan Maintains Neutral -> Neutral
2023-06-06 Needham Reiterate Buy -> Buy
2023-05-05 Needham Maintains Buy
2023-04-12 Wells Fargo Maintains Underweight
2023-04-05 Needham Reiterate Buy
2023-03-02 Needham Maintains Buy
2023-03-02 Wells Fargo Maintains Underweight
2023-03-02 JP Morgan Maintains Neutral
2023-01-09 Wells Fargo Maintains Underweight
2022-11-02 Needham Maintains Buy